249) ession is significantly down-regulated in tumor tissue and CRC cell lines compared w |
250) on, short half-life, low concentration in tumor tissue and systemic toxicity. |
251) , 62 pairs of samples from patients whose tumor tissue showed hypermethylation of AN |
252) d and could be accumulated effectively in tumor tissue via the enhanced permeability |
253) rate was accumulated more effectively in tumor tissue. |
254) A small amount of tumor-like tissue was observed on the wall |
255) A tumor with a high level of Ki67 should be |
256) that surgical specimen displayed a solid tumor with both CLL/SLL and MCC components |
257) d strong FDG uptake (SUVmax, 34.5) of the tumor with ipsilateral hilar lymph node me |
258) Histologically, a tumor with islands of oncocytic epithelial |
259) Surgical resection of the tumor with partial resection of phrenic an |
260) ial diagnosis included primary pancreatic tumor with small cell morphology as well a |
261) Tumor angiogenesis is essential for tumor |
262) k between VEGF and MTA1 protein regulates tumor angiogenesis and metastasis. |
263) NAs (miRNAs) were important regulators of tumor angiogenesis and the entire research |
264) ecific miRNAs intersect with and modulate tumor angiogenesis is still unclear. |
265) e stochastic 3D model & simulation of tumor-induced angiogenesis. |
266) l the potential mechanism of lidamycin on tumor initiating cells and the benefit for |
267) Recently, tumor initiating cells are considered as t |
268) evaluate the effect of lidamycin on Huh7 tumor initiating cells in vitro. |
269) , we evaluated the effect of lidamycin on tumor initiating cells of hepatocellular c |
270) ts suggest that lidamycin suppressed Huh7 tumor initiating cells via GSK3β/β-caten |
271) In addition to loss of tumor suppressive function, tumor-associat |
272) that induction of apoptosis is a key p53 tumor suppressive function. |
273) owever, indicate that other undefined p53 tumor suppressive functions are operative |
274) retinoblastoma (Rb) and p53 have critical tumor suppressive functions in retinoblast |
275) enesis, and identify essential Rb and p53 tumor suppressive functions in vivo. |
276) In addition, lidamycin restrained tumor volume and incidence in vivo. |
277) the semiquantitative evaluation of total tumor volume in the node when a whole node |
278) The results showed the tumor volume of GLUT-1-siRNA-MG63 cells xe |
279) ring rats indicated significantly reduced tumor volume with cisplatin-loaded targete |
280) line that encompassed at least 90% of the tumor volume. |
281) f the zebrafish Danio rerio as an in vivo tumor model for studying non-targeted effe |
|